RayzeBio

RayzeBio is a biotechnology company dedicated to improving cancer treatment outcomes through the development of targeted radiopharmaceuticals. They specialize in creating novel drug conjugates that deliver potent therapeutic radioisotopes like Actinium-225, an alpha-emitter, to specific targets within solid tumors. Their lead asset, RYZ101, is currently undergoing Phase 3 testing for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and earlier-stage testing for patients with small cell lung cancer (SCLC).

The company is vertically integrated, with its own research facilities in San Diego and a manufacturing plant in Indianapolis. This allows RayzeBio to control the entire development process, from discovery and research through manufacturing and commercialization. They are committed to a data-driven approach and have completed over 500 in vivo studies to inform their research and development, positioning them as a leader in the emerging radiopharmaceutical therapy modality.

RayzeBio offers a range of job flexibility options, including remote work arrangements for certain positions. For example, the Manager, Clinical Site Operations and Manager, Clinical Program Management roles are both remote, and other positions may have flexible work schedules or the ability to work from home occasionally.

RayzeBio offers a comprehensive total rewards package to all employees, which includes benefits such as health insurance, dental insurance, vision insurance, and a 401(k) plan. The company also provides paid time off, sick leave, and short-term and long-term disability insurance.

RayzeBio is a biotechnology company committed to improving cancer treatment outcomes through targeted radiopharmaceuticals. They focus on developing novel drug conjugates that deliver potent therapeutic radioisotopes, particularly Actinium-225, to clinically validated solid tumor targets. Their vertically integrated approach, encompassing discovery, development, and manufacturing, aims to establish a leadership position in the emerging radiopharmaceutical therapeutics modality.

RayzeBio promotes a dynamic and collaborative work environment where passionate, truth-seeking individuals can make a meaningful impact in improving cancer treatment outcomes. They value their employees, fostering a collegial, inclusive, and honest team culture that encourages efficient work while emphasizing the importance of having fun and finding the right path forward.

RayzeBio prioritizes a collegial, inclusive, and honest team culture, valuing employees and striving to create a dynamic work environment. They are committed to diversity, equity, and inclusion, seeking passionate truth-seeking individuals who are driven to make a positive impact on cancer treatment outcomes. This commitment is evident in their diverse leadership team and their efforts to recruit and retain a workforce that reflects the communities they serve.